Business News

Aker BioMarine receives third straight “A” rating from Sustainable Fisheries Partnership

20 Nov 2017 --- Aker BioMarine’s krill fishery in the Antarctic has received an “A” rating from The Sustainable Fisheries Partnership (SFP) for the third year in a row. The Reduction Fisheries: SFP Fisheries Sustainability Overview 2017 analyzed 20 of the most significant fisheries used for the production of fishmeal or fish oil and assessed the sustainability of the current management regimes.

BASF plant fire: Force Majeure for vitamins and carotenoids at Citral plant

10 Nov 2017 --- BASF has announced that it has shut down its Citral plant in Ludwigshafen, Germany, and has had to declare Force Majeure for its Citral- and Isoprenol-based aroma ingredients following a fire on October 31 during the startup of the plant.

Glanbia seals US convenience store expansion with major Kum & Go deal

10 Nov 2017 --- Glanbia Performance Nutrition (GPN) has announced that beginning this week, 344 locations of the family-owned US convenience store Kum & Go will offer GNP's Cake Bites in the Chocolate Frosted Donut and Berry Cheesecake flavors. GPN’s Optimum Nutrition Cake Bites, described as “whipped, bite-sized cakes that satisfy snack cravings with high-quality dairy protein and much less sugar than most candy options.” 

Ajinomoto enters US medical foods market with Cambrooke Therapeutics acquisition

09 Nov 2017 --- Ajinomoto Co. Inc has acquired an equity position in US medical foods company Cambrooke Therapeutics, Inc through Ajinomoto North America, Inc. (Ajina) for approximately US$64 million and made it a wholly owned subsidiary. Founded in 2000, Cambrooke develops and manufactures medical foods for patients with amino acid metabolism disorders and other customers. 

Frutarom fortifies portfolio with acquisition of AB-Fortis activity

08 Nov 2017 --- Frutarom has signed an agreement with AB-Biotics S.A. of Spain for the acquisition of the activity of AB-Fortis. The patent-protected micro-encapsulation technology enables delivery of iron with increased biological absorption while avoiding the side effects of metallic taste and digestive problems in the applications of functional foods and dietary supplements.

Microbiome Therapeutics prepares to launch first microbiome modulator after completing Series B financing

08 Nov 2017 --- MicroBiome Therapeutics, LLC (MBT), a company that applies the science of the gastrointestinal (GI) microbiome to promote health and wellness, has announced the completion of a Series B financing that raised approximately US$1 million. MBT intends to use the proceeds to launch its clinically-tested microbiome modulator product in 2018.

Omega Protein employees and supporters urge Atlantic fisheries commission to protect menhaden jobs

08 Nov 2017 --- 457 Omega Protein employees and supporters have signed a petition urging the Atlantic States Marine Fisheries Commission (ASMFC) to protect the jobs created by the Atlantic menhaden fishery. 

New MenaQ7 patents granted to NattoPharma in US, Israel and Australia

08 Nov 2017 --- NattoPharma ASA has successfully secured patents in Israel, the US and Australia for its “nature-identical synthesis” creating MenaQ7 PharmaPure Vitamin K2 as MK-7, adding further to the company’s patent portfolio.

Innophos acquires NutraGenesis to boost its Food, Health and Nutrition portfolio

07 Nov 2017 --- Innophos Holdings has acquired NutraGenesis, a Vermont, US-based marketer of proprietary, branded and science-backed nutraceutical ingredients. This transaction builds on the momentum from its recent acquisition of Novel Ingredients and further advances Innophos’ Vision 2022 strategic priorities to grow its Food, Health and Nutrition portfolio, increase its presence in attractive nutrition end-markets and develop innovative solutions that better serve its customers.

BASF to enter US medical foods market with product to manage NAFLD

06 Nov 2017 --- BASF and DIEM Labs have entered into a distribution agreement to commercialize BASF’s first US medical food product for the dietary management of patients with non-alcoholic fatty liver disease (NAFLD). As part of this agreement, BASF has announced that it will use its scientific expertise and state-of-the-art manufacturing capabilities to provide a first-to-the-market medical food product to patients with NAFLD. 

Omega 3 fatty acids linked to more positive lupus outcomes by study

06 Nov 2017 --- Higher intake of omega 3 fatty acids was associated with better sleep quality and a decrease in depressive symptoms in lupus patients, among other patient-reported outcomes, according to new research findings presented at the 2017 American College of Rheumatology/Association of Rheumatology Health Professionals Annual Meeting in San Diego, California, US.

Oils and more: Neptune explores new frontiers in cannabis space

06 Nov 2017 --- Thanks to the complex regulatory situations surrounding the ingredient in various countries around the world, cannabis products currently do not have a clear roadmap for success. However, this doesn’t mean that there are not opportunities in the space. One company currently making a mark in the industry is Neptune Wellness Solutions.

Vitamin E discovery in maize could lead to more nutritious crop in future

03 Nov 2017 --- New research from Cornell University, US, has identified genes that control vitamin E content in maize grain, a finding that could lead to an improvement in the nutritional profile of the staple crop.

Bifodan expands global presence with new office in Milan

03 Nov 2017 --- Danish probiotics company Bifodan has established a regional sales office in Milan, Italy. The move increases its global presence to four offices on the European continent and three offices in the US, from which it intends to serve the global market.

DSM’s Nutrition segment contributes strongly to “very good” Q3 performance

02 Nov 2017 --- DSM’s results for the first nine months of 2017 show strong outcomes in the company’s nutrition sector. Overall highlights of the results, buoyed by an especially impressive Q3 performance, include a 9 percent increase in sales to €6.46 billion (US$7.51 billion), with 8 percent organic growth. The adjusted EBITDA is up 15 percent to €1.08 billion, driven by both Nutrition and Materials, and the company’s outlook for 2017 is unchanged.

CVS Health’s potential US$66bn move to buy Aetna Inc. raises concerns

01 Nov 2017 --- A few days after US pharmacy operator CVS Health Corp reportedly made a potentially market-changing offer to acquire health insurer Aetna Inc. for more than US$200 per share, or over US$66 billion, analysts have questioned whether it could mark the preparation for Amazon’s arrival in the market and spark antitrust concerns. Since the move was reported, it has raised questions over whether Amazon’s supposed intentions in moving into the prescription drug industry are truly motivating the acquisition and whether the consolidation would be blocked by regulators.

Glanbia Performance Nutrition “main driver” of company’s revenue growth in first nine months of 2017

01 Nov 2017 --- Global nutrition group Glanbia plc. has highlighted strong performances from Glanbia Performance Nutrition and Glanbia Nutritionals in its Interim Management Statement for the nine-month period ending on September 30 2017. The highlights include a 9 percent increase in revenues for Glanbia Performance Nutrition and a 4.6 percent revenue growth for Glanbia Nutritionals.
 

QHT short-chain inulin and galactooligosaccharide meet Chinese national standards

01 Nov 2017 --- Quantum Hi-Tech Biological Co., Ltd. (QHT) has announced that it is leading a “national standard sample era” of short-chain inulin and galactooligosaccharide (GOS). The company’s research into inulin and GOS national standard samples has achieved great success, the company says.

Roquette focuses on “patient-friendly” dosage forms

31 Oct 2017 --- Following the launch of its new market segment focusing on nutritional and dietary supplements, Roquette is seeking to respond to consumer preferences for nutritional supplements by targeting patient-friendly dosage forms based on natural ingredients. This is according to Kelsey Achenbach, Head of Marketing – Pharma at Roquette, who spoke to NutritionInsight at CPhI in Frankfurt. 

DSM, UNICEF and Sight and Life partner up to deliver improved nutrition to Nigerian children and mothers

31 Oct 2017 --- Royal DSM, UN children’s agency UNICEF and Swiss-based humanitarian nutrition think tank Sight and Life have partnered to deliver better nutrition to at-risk children and mothers in Nigeria. The partners will also advocate on a global scale for micronutrient supplementation. As part of the project, DSM is to offer essential vitamins, nutrients and fortification solutions as well as expertise that complements the research, programs, and global reach of UNICEF and Sight and Life.